While the world has experienced tremendous growth in the last decades, there are still some concerns needing to be addressed. One of these is substance abuse, which has been draining healthcare budgets, negatively impacting jobs, and putting people in danger. However, medical and technological advances have enabled government agencies, healthcare professionals, employers, and individuals to make progress in the fight against substance abuse and its broader consequences. As American Screening LLC (ASC) can attest, rapid drug tests have become one of the most useful diagnostic tools in modern society, providing fast and accurate results that often save lives or enhance business results by improving the decision-making process. American Screening LLC, a leadingISO13485 contract manufacturer and distributor of diagnostic products and essential medical supplies, maintains a robust inventory of rapid drug testing kits to help public organizations, corporate entities, and regular citizens act quickly and minimize the risk of any substance abuse-related problems escalating.
From its inception, the company has been committed to offering products of the highest quality at affordable prices along with supporting efforts to combat drug addiction. American Screening LLC says that even though they grew into a major organization with operations across the globe, their core mission has remained the same. An important part of it is providing cost-effective and efficient solutions for addressing this serious problem. They say that their inventory grows constantly, but they made it a priority to always have in stock an array of rapid tests for drugs due to their realization of the importance of these products. ASC adds that whether in the workplace, at home, or in a law enforcement setting, these kits become crucial as illicit substance use increases. Their extensive range features tests that can detect from one to as many as 12 drugs of abuse with accuracy of up to 99%. These kits make it easy to check for the presence of the most commonly used drugs, including marijuana, cocaine, fentanyl, oxycodone, opiates, methamphetamine, amphetamines, K2, ETG, phencyclidine (PCP), benzodiazepine, barbiturates, methadone, and ecstasy (MDMA).
The importance of rapid drug tests is underscored by the fact that this segment of the drug abuse testing market is expected to register the strongest growth in the years ahead, American Screening LLC notes. According to Allied Market Research, total industry revenues will rise by 8.2% annually from 2017 to 2025, increasing from $6.24 billion to $11.83 billion over the specified period. Notably, the report projects a compound annual growth rate of 14.2% for the rapid testing products segment due to its advantages such as accuracy in results and in less time and advent of technologically advanced devices. For American Screening LLC, providing a rich choice of rapid drug tests is a way to ensure optimal outcomes for all parties concerned, be it in emergency medical settings, corporate environments, or public places. Its products empower healthcare professionals, law enforcement officers, employers, and family members to make the right decisions and act quickly, thus preventing or rectifying situations with potentially fatal consequences.
American Screening LLC started in a small room in Shreveport, Louisiana as a family business on a mission to provide quality drug and alcohol testing products. Since its launch in 2004, the company has expanded steadily to become a top vendor of diagnostic tests and essential medical supplies to the United States, South America, Asia, Africa, Europe, and Australia. Much of its success is attributable to the founder, Ron Kilgarlin, who drew on his extensive expertise in business management, medical devices, product development, distribution, and marketing. Among the many things American Screening LLC takes pride in are its multiple certifications, including the highly coveted one issued under MDSAP (Medical Device Single Audit Program), which designates the company as compliant with the requirements for quality management systems in multiple jurisdictions.
American Screening, LLC Now Offers COVID-19 Antibody Rapid Serology Tests: https://www.biospace.com/article/releases/american-screening-llc-now-offers-covid-19-antibody-rapid-serology-tests/
American Screening LLC Founder, Ron Kilgarlin, on Improved Efficiency in Decision-Making with Rapid Drug Tests: https://apnews.com/article/coronavirus-pandemic-business-technology-health-4984166f0d2a716baa5137741175445b